佩吉特骨病患者全髋与全膝关节置换术后的结局:一项系统综述
该系统综述检索MEDLINE、EMBASE和Cochrane数据库,纳入19篇文献(1976年至2022年发表),共58,695例患者(对照组48,766例,佩吉特骨病患者10,018例),评估其全髋与全膝关节置换术后的结局。佩吉特骨病患者全髋置换术后平均7.8年(范围0.1至20年)的合并死亡率为32.5%,全膝置换术后平均8.5年(范围2至20年)的合并死亡率为31.0%;全髋置换术后7.2年(范围0至20年)的合并翻修率为4.4%,全膝置换术后7.4年(范围2至20年)的合并翻修率为2.2%。作者认为佩吉特骨病患者接受全髋与全膝关节置换术的假体存留率似乎与未患病者相似,但医疗与手术并发症风险似乎增加,且可能因手术而具有更高的死亡风险。
要点
- 佩吉特骨病患者全髋置换术后平均7.8年合并死亡率为32.5%,全膝置换术后平均8.5年为31.0%。
- 全髋置换术后7.2年合并翻修率为4.4%,全膝置换术后7.4年合并翻修率为2.2%。
- 肾与呼吸系统并发症、异位骨化和手术部位感染是最常见的术后并发症。
核心结论
- 评估佩吉特骨病患者关节置换术结局的研究在结局报告上存在显著异质性,研究质量低至中等。
- 佩吉特骨病患者接受全髋与全膝关节置换术的假体存留率似乎与未患病者相似。
- 佩吉特骨病患者接受全髋与全膝关节置换术的医疗与手术并发症风险似乎增加,且可能因手术而具有更高的死亡风险。
研究设计与样本
- 系统综述,检索MEDLINE、EMBASE和Cochrane数据库中所有评估佩吉特骨病患者全髋与全膝关节置换术后结局的文章。
- 共纳入19篇文章(1976年至2022年发表),包含58,695例患者(对照组48,766例,佩吉特骨病患者10,018例),来自209个可能相关的标题。
- 纳入研究质量采用纽卡斯尔-渥太华量表评估。
主要发现
- 佩吉特骨病患者全髋置换术后平均7.8年(范围0.1至20年)的合并死亡率为32.5%。
- 佩吉特骨病患者全膝置换术后平均8.5年(范围2至20年)的合并死亡率为31.0%。
- 佩吉特骨病患者全髋置换术后7.2年(范围0至20年)的合并翻修率为4.4%。
- 佩吉特骨病患者全膝置换术后7.4年(范围2至20年)的合并翻修率为2.2%。
- 肾与呼吸系统并发症、异位骨化和手术部位感染是最常见的术后并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 评估佩吉特骨病患者关节置换术结局的研究在结局报告上存在显著异质性,研究质量低至中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who have Paget's Disease more frequently require total hip arthroplasty (THA) and total knee arthroplasty (TKA) than matched controls. However, controversy remains regarding their outcome. We aimed to evaluate the literature regarding outcomes following THA and TKA in patients who have Paget's Disease. METHODS: MEDLINE, EMBASE and Cochrane databases were searched for all articles evaluating outcomes following THA and TKA in patients who have Paget's Disease. Quality of included studies was assessed using the Newcastle-Ottawa Scale. RESULTS: A total of 19 articles (published between 1976 and 2022) were included, comprising 58,695 patients (48,766 controls and 10,018 patients who have Pagets Disease), from 209 potentially relevant titles. Patients with Paget's Disease have a pooled mortality of 32.5% at a mean of 7.8 years (range, 0.1 to 20) following THA and 31.0% at a mean of 8.5 years (range, 2 to 20) following TKA, with a pooled revision rate of 4.4% at 7.2 years (range, 0 to 20) following THA and 2.2% at 7.4 years (range, 2 to 20) following TKA. Renal and respiratory complications, as well as heterotopic ossification and surgical-site infection were the most common post-operative complications. CONCLUSION: There is marked heterogeneity in outcome reporting of studies assessing arthroplasty in patients who have Paget's Disease, with studies of low to moderate quality. Patients with Paget's Disease undergoing THA and TKA appear to have similar implant longevity as their unaffected counterparts. However, they appear to have an increased risk of medical and surgical complications and may have a higher mortality risk from their procedure.
引用
- Arif M, Makaram NS, Macpherson GJ, et al. Outcomes following Total Hip and Knee Arthroplasty in Patients Who Have Paget's Disease of Bone: A Systematic Review. J Arthroplasty. 2023. PMID: 36639114. doi:10.1016/j.arth.2023.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。